Homepage | Overview | Markets in Detail | Company Finances | Investing Ideas | Personal Finance | Press Releases | Member Center
Hot Keywords
current page:home>Press Releases>Marketwire>Article

Active Biotech's Election Committee Appointed

This Site:en.yinlu.net Source:en.yinlu.net Writer: Time:2007-11-22
LUND, SWEDEN--(MARKET WIRE)--Nov 22, 2007 -- In accordance with the decision bythe Annual General Meeting onApril 19, 2007, the election committee shall consist ofrepresentatives from the three largest shareholders as atthe endofOctober and the Chairman of the Board.

The election committee for the next Board election consistsofJohnnySommarlund for MGA Holding, Tomas Billing for NordstjernanandUlfStrömsten for Catella funds.

Headed by the Chairman of the Board, Mats Arnhög, theelectioncommittee will prepare a proposal for the composition ofthe Boardtobe presented to the Annual General Meeting on 7 May, 2008.

 Lund, November 22, 2007Active Biotech AB (publ)Sven AndréassonPresident and CEO

Active Biotech AB (OMX Nordic: ACTI) is a biotechnologycompanyfocusing on research and development of pharmaceuticals.ActiveBiotech has a strong R&D portfolio with pipeline productsfocusedonautoimmune/inflammatory diseases and cancer. Most advancedprojectsare laquinimod, an orally administered small molecule withuniqueimmunomodulatory properties for the treatment of multiplesclerosis,as well as ANYARA for use in cancer targeted therapy, primarilyrenalcancer. Further key projects in clinical development comprisethethree orally administered compounds TASQ for prostate cancer,57-57for SLE and RhuDex® for RA. In addition, the autoimmunityprojectI-3D is in preclinical development.

Copyright © Hugin ASA 2007. All rights reserved.

User:New Register) Password: Anonymity
Commentary Content
New Commentary
Hot ArticleHot Article
Correlation ArticleCorrelation Article
More LinkMore Link
站长推荐: |